Increasing prevalence of infectious diseases, rise in antibiotic resistance, increasing adoption of precision medicine, and research & development focused on analytical instrument are key attributes contributing towards the growth of the global antimicrobial susceptibility test market. Majority of the infectious diseases are of bacterial origin and demand precise antibiotics.
However, with increasing consumption of antibiotics, the antibiotic resistance of individuals has increased significantly due to the genetic mutation incorporated by the bacteria for survival in the host body. Consequently, the demand for precision medicine has increased significantly around the globe.
The antimicrobial susceptibility test is conducted before initiating treatment for infectious diseases. Wherein, the individual is prescribed with appropriate and effective medication based on the test results. This has fueled the demand for antimicrobial susceptibility test equipment, and consumables. The global antimicrobial susceptibility test market is anticipated to witness significant growth during the forecast period.
North America contributed the largest share to the global antimicrobial susceptibility test market in 2019 and is anticipated to witness prominent growth during the forecast period due to the presence of leading manufacturers of analytical instruments, high penetration of precision medicines, and string healthcare infrastructure.
Asia Pacific is expected to be the most lucrative market during the forecast period owing to increasing awareness and rising adoption of precision medicines, prevalence of infectious diseases, and expanding geriatric population. Increasing investment in expansion of pharmaceutical manufacturing is another factor supporting the growth of antimicrobial susceptibility test market in coming years.
Antimicrobial Susceptibility Test Market Share Analysis, by Geography (2021)
The report titled “Antimicrobial Susceptibility Test Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032” wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global antimicrobial susceptibility test market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Thermo Fisher Scientific Inc. reported revenues of USD 24.4 billion in 2018 and the product segment analysis of the company indicates that the Laboratory Products & Services business segment of the company dominated revenue in 2018.
The global antimicrobial susceptibility test market is segmented based on type, product type, method, application, end user, and geography. Based on type, the global antimicrobial susceptibility test market is segmented into antibacterial testing, antifungal testing, antiparasitic testing, and other. Based on product type, the global antimicrobial susceptibility test market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, susceptibility testing disks, minimum inhibitory concentration (MIC) strips, susceptibility plates, culture and growth media, and consumables. Based on method, the global antimicrobial susceptibility test market is segmented into dilution, disk diffusion, Epsilometer test (ETEST), automated antimicrobial susceptibility testing, and genotypic methods. Based on applications, the global antimicrobial susceptibility test market is segmented into clinical diagnostics, drug discovery and development, epidemiology, and other. Based on end user, the global antimicrobial susceptibility test market is segmented into diagnostic centers and hospitals, pharmaceutical and biotechnology companies, contract research organizations (CROS), research and academic institutes. Based on geography, the global antimicrobial susceptibility test market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on antimicrobial susceptibility test equipment, reagents and technology. Further, market share of prominent companies in the global antimicrobial susceptibility test market would also be estimated.
For instance, Thermo Fisher Scientific Inc. operates through four business segments namely Life Sciences Solutions, Laboratory Products & Services, Specialty Diagnostics, and Analytical Instruments. The antimicrobial susceptibility test products are delivered under Laboratory Products & Services business segment of the company with revenue contribution of US$ 9.52 billion in 2018.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the antimicrobial susceptibility test equipment and consumable manufacturers. Furthermore, the global antimicrobial susceptibility test market study would take into consideration the participants engaged throughout the value chain and supply chain of the market, along with their contribution.
Product portfolio would focus on all the products under the antimicrobial susceptibility test business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global antimicrobial susceptibility test market.
Major players active in the global antimicrobial susceptibility test market include Accelerate Diagnostics, Inc., Alifax S.r.l. Italy, BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Creative Diagnostics, Danaher Corporation, HiMedia Laboratories, Liofilchem S.r.l., Merck Group, Merlin (A Bruker Company), and Thermo Fisher Scientific.
The Global Antimicrobial Susceptibility Test Market Is Segmented
Based On Type
Based On Product Type
Based On Method
Based On Applications
Based On End User
Based On Geography
The Antimicrobial Susceptibility Test market is studied from 2022 to 2032.
The major players are Accelerate Diagnostics, Inc., Alifax S.r.l. Italy, BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Creative Diagnostics, Danaher Corporation, HiMedia Laboratories, Liofilchem S.r.l., Merck Group, Merlin (A Bruker Company), and Thermo Fisher Scientific. .
The major applications of Antimicrobial Susceptibility Test include Clinical Diagnostics, Drug Discovery And Development, Epidemiology and Other..
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved